Sarcoma & GIST
News
Long-term follow-up shows 22% survival rate for advanced GIST
Major finding: Ten-year overall survival for patients with metastatic or unresectable gastrointestinal tumors (GIST) treated with imatinib was 22...
News
Launch of rare-cancer trial spurs many more
News
Pazopanib helps significant minority of sarcoma patients
News
The push for smaller, smarter cancer trials
News
Doxorubicin, ifosfamide combination touted for advanced sarcomas
News
Some consider denosumab standard treatment for unresectable giant cell tumor of bone
News
Europe’s latest sarcoma guidelines increase emphasis on genetic profiling
News
Role for GIST genotyping stirs controversy
News
Liquid biopsies may solve GIST biopsy problem
News
Pazopanib shows promise as pediatric sarcoma therapy
Major finding: Results of the DCE-MRI analysis showed a decrease in tumor blood volume from a mean of 16% at the start of treatment to 7% at the...
News
Ridaforolimus offers moderate maintenance benefit in advanced sarcoma
Major finding: Mean PFS was 17.7 weeks vs.